How dexamethasone dose affects recovery and quality of life after total hip replacement
Official title: The Effect of Corticosteroids on Quality of Life Following Total Hip Arthroplasty: HIPSTER Study
Run by Ziekenhuis Oost-Limburg · NCT07378215 · Data updated 2026-11-12
This trial will test whether a single low (5 mg) or higher (25 mg) dose of dexamethasone given during surgery helps people aged 60 and older recover faster and have better quality of life in the three months after total hip replacement.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 224 (estimated) |
| Sponsor | Ziekenhuis Oost-Limburg Academic / other |
| Locations | 2 sites (Genk, Limburg and 1 other locations) |
| Status | Recruiting |
| Started | January 30, 2026 |
| Main results expected | February 2027 |
| Study ends | February 2027 |
| Registry record updated | April 8, 2026 |
| Trial ID | NCT07378215 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 60 or older scheduled for elective total hip arthroplasty under spinal anaesthesia who can give informed consent and are not on chronic systemic corticosteroids.
✕Probably not a fit
Patients who may not benefit include those having revision or bilateral hip replacements, those on chronic systemic steroids, people with steroid hypersensitivity or active gastrointestinal ulcers, and patients requiring urgent or non-elective surgery.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The HIPSTER trial compares a single intraoperative IV dose of dexamethasone 5 mg versus 25 mg in older adults undergoing elective total hip arthroplasty under spinal anaesthesia. Participants receive one of the two doses during surgery and are followed for health-related quality of life and persistent pain up to three months postoperatively. The study builds on ERAS practices that use corticosteroids to reduce acute postoperative pain, nausea and fatigue, while specifically measuring longer-term patient-reported outcomes. Enrollment and follow-up take place at Ziekenhuis Oost-Limburg with standard perioperative care otherwise unchanged.
Why it matters
Potential benefit: If successful, finding the optimal dexamethasone dose could improve postoperative pain, fatigue, nausea and overall quality of life after hip replacement.
How similar studies have gone: Previous studies show single perioperative dexamethasone doses reduce short-term pain, nausea and fatigue after orthopedic surgery, but evidence on effects on quality of life beyond the immediate postoperative period is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged 60 years or older; * scheduled for elective total hip arthroplasty; * procedure under spinal anaesthesia. Exclusion Criteria: * hip revision surgery (reoperation); * bilateral total hip arthroplasty during the same procedure; * known hypersensitivity to dexamethasone or other corticosteroids; * chronic systemic use of corticosteroids, defined as daily corticosteroid therapy for \> 4 weeks within the last 3 months, with anticipated need for a perioperative stress dose of corticosteroids; * active gastric of intestinal ulcers; * lack of informed consent or inability to give informed consent; * urgent, non-elective surgery.
Where it's running
-
Ziekenhuis Oost-Limburg
Genk, Belgium Recruiting -
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium Not yet recruiting
Study contacts
- Study coordinator: Steven Thiessen
- Email: steven.thiessen@zol.be
- Phone: 3289804646
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Telecare psychosocial and cognitive program for kids with limb-girdle muscular dystrophy
A telecare-based group program is tested to see if it helps 7- to 17-year-olds with limb-girdle muscular dystrophy improve quality of life and social skills.
-
See if an interprofessional health needs assessment improves quality of life for older adults living at home
This randomized trial tests whether an interprofessional health needs assessment helps people 65 and older living at home have better health-related quality of life and use health services more appropriately.
-
Health Ahead: Comparing AI vs. Humans for Preventive Health Screening
This study tests AI-assisted screening interpretation against human-only reads to see if automated screening can match or improve current practice for adults, especially in underserved areas.
-
Mobile-based telemedicine to improve quality of life for chronic heart failure patients
We’re testing whether a mobile phone–based program that sends reminders, education, and follow-up can improve quality of life for adults with chronic heart failure in Ethiopia.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
-
Intergenerational Mentoring to Reduce Loneliness and Improve Well-Being
This project tests intergenerational mentoring between seniors 60+ and youths aged 12–21 in Hamburg to see if it reduces loneliness and improves mental well-being and quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.